Effect of LIK066 on Glucose Absorption in Patients With Type 2 Diabetes Mellitus

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Type 2 Diabetes Mellitus

In brief

The purpose of the study was to assess the effect of LIK066 on intestinal glucose absorption immediately after a single dose (immediate effect) and 6 hours following the dose (after multiple daily doses; sustained effect) in patients with type 2 diabetes mellitus (T2DM).

Key facts

Study ID
NCT01915849
Run by
Novartis Pharmaceuticals
People needed
14
Starts
2013-07-01
Expected to finish
2014-01-01
Last updated by the study team
2015-02-06

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.